New York, March 18, 2020 (GLOBE NEWSWIRE) — According to the current analysis of Reports and Data, the global Urinary Incontinence market was valued at USD 2.18 billion in 2018 and is expected to reach USD 3.93 billion by the year 2026, at a CAGR of 7.6%. Urinary incontinence is the leakage of urine, which is not controllable and is caused due to loss of control on the bladder. The various factors which are responsible for urine leakage include multiple conditions such as pregnancy, menopause, pelvic surgery, spinal surgery, diabetes, childbirth, and post radical prostatectomy surgery. The crucial factors responsible for propelling the market include the rising prevalence of the physical and medical conditions leading to urinary incontinence, increase in the geriatric population in the forecast period. For instance, according to the International Diabetes Federation estimates, half a billion people are found to be living with diabetes worldwide, and the number is projected to increase by 25% in 2030 and 51% in 2045. This rise in diabetic patients who undergo problems with urination is anticipated to fuel the market in the near future.
Request free sample of this research report at: https://www.reportsanddata.com/sample-enquiry-form/2741
Additionally, the growing incidences of Parkinson’s disease and hike in the technological advancements of urinary incontinence, upsurge in the government initiatives for the awareness, and increase in healthcare spending are anticipated to propel the market in the coming years. For instance, according to the recent estimations of the Parkinson’s Foundation, it is estimated that more than 10 million people worldwide are living with Parkinson’s disease worldwide. The increase in the individuals living with Parkinson’s diseases is also more susceptible to experience urinary incontinence and hence propel the market in the near future.
Besides, the lesser awareness regarding urinary incontinence symptoms, post-operative problems such as infections related to the devices, are expected to hamper the growth of the market.
Further key findings from the report suggest
- According to the classification given by the Food and Drug Administration, the mesh, surgical, synthetic, urogynecology, was declared implantable conferring to the Life-Saving and Life-Sustaining Devices for purposes of Section 614 of FDASIA amending Section 519(f) of the FDC Act. The approval of such products is expected o fuel the growth of the market in the coming years.
- In Jan 2020, Medtronic received CE mark for the rechargeable sacral neuromodulation technology for its InterStim Micro neurostimulator and InterStim SureScan MRI leads, clearing the technologies for sale in Europe.
- The global market leaders are developing technologies to combat the competition for the growing need for minimally invasive urinary incontinence devices which are anticipated to boost the market. For instance, recently Axonics won FDA approval for the first rechargeable sacral neuromodulation device.
- The increasing appreciations for the technological advancements would allow upsurge in the innovation in the coming years. For instance, in 2019 UroMems, a developer of the eAUS electronic artificial urinary sphincter received the 2019 Prix Galien USA Med’Start-Up Award for best collaboration in the Medtech or digital sector for its collaboration with the Mayo Clinic to design a clinical study for a novel medical device to treat patients with stress urinary incontinence (SUI)
- The global Urinary Incontinence market is highly fragmented with major players like Covidien plc (Medtronic), Coloplast, Boston Scientific Corporation, C. R. Bard, Inc., ConvaTec Group Plc, Ethicon, Inc., Caldera Medical Inc., Cook Medical, Prosurg, Inc., and Cogentix Medical Inc.
Order Now: https://www.reportsanddata.com/checkout-form/2741
For the purpose of this report, Reports and Data has segmented the Urinary Incontinence market on the basis of products, types, categories, end-use and region:
Products Outlook (Revenue in Million USD; 2016–2026)
- Urinary Catheters
- Foley
- Suprapubic
- Intermittent
- Electrical stimulation devices
- Non-implantable
- Implantable
- Urethral Slings
- Neuromodulation Devices
- Artificial Urinary Sphincters
- Others
Types Outlook (Revenue in Million USD; 2016–2026)
- Stress
- Urge
- Mixed
- Overflow
- Functional
- Total Incontinence
- Others
Categories Outlook (Revenue in Million USD; 2016–2026)
End-Use Outlook (Revenue in Million USD; 2016–2026)
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Home Use
- Others
To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/urinary-incontinence-market
Regional Outlook (Revenue in Million USD; 2016–2026)
- North America
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of the Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia-Pacific
- Middle East & Africa
- Latin America
Browse more similar reports on Medical Devices category by Reports And Data
Dental X-Ray Market – https://www.reportsanddata.com/report-detail/dental-x-ray-market
Artificial Ventilators and Anesthesia Masks Market – https://www.reportsanddata.com/report-detail/artificial-ventilators-and-anesthesia-masks-market
Apheresis Equipment Market – https://www.reportsanddata.com/report-detail/apheresis-equipment-market
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us: John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: [email protected]
